Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
2000 1
2006 1
2012 3
2020 3450
2021 14146
2022 19406
2023 12823
2024 3529

Text availability

Article attribute

Article type

Publication date

Search Results

48,355 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
However, some viral vector or mRNA vaccines may be associated with complications like thrombocytopenia and myocarditis, raising concerns about the safety of these COVID-19 vaccines. Here, we systemically assess the safety and efficacy of COVID- …
However, some viral vector or mRNA vaccines may be associated with complications like thrombocytopenia and myocarditis, raising conce …
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Tregoning JS, et al. Nat Rev Immunol. 2021 Oct;21(10):626-636. doi: 10.1038/s41577-021-00592-1. Epub 2021 Aug 9. Nat Rev Immunol. 2021. PMID: 34373623 Free PMC article. Review.
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries. ...Where they have been deployed in a high proportion of …
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unp …
Covid-19 vaccines and variants of concern: A review.
Hadj Hassine I. Hadj Hassine I. Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9. Rev Med Virol. 2022. PMID: 34755408 Free PMC article. Review.
Currently, nine Covid-19 vaccine candidates based on the original Wuhan-Hu-1 strain are at the forefront of vaccine research. ...Promising Covid-19 vaccines such as WIBP-CorV, AD5-nCOV, ZyCoV-D, CVnCoV, EpiVacCorona and ZF2001 have advanc …
Currently, nine Covid-19 vaccine candidates based on the original Wuhan-Hu-1 strain are at the forefront of vaccine res …
Oxford-AstraZeneca COVID-19 vaccine efficacy.
Knoll MD, Wonodi C. Knoll MD, et al. Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8. Lancet. 2021. PMID: 33306990 Free PMC article. No abstract available.
[Comment] COVID-19 vaccine safety.
Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. Kostoff RN, et al. Int J Mol Med. 2020 Nov;46(5):1599-1602. doi: 10.3892/ijmm.2020.4733. Epub 2020 Sep 18. Int J Mol Med. 2020. PMID: 33000193 Free PMC article.
In response to the SARS-CoV-2 outbreak, and the resulting COVID-19 pandemic, a global competition to develop an anti-COVID-19 vaccine has ensued. ...
In response to the SARS-CoV-2 outbreak, and the resulting COVID-19 pandemic, a global competition to develop an anti-COVID
COVID-19 vaccine induced myocarditis in young males: A systematic review.
Knudsen B, Prasad V. Knudsen B, et al. Eur J Clin Invest. 2023 Apr;53(4):e13947. doi: 10.1111/eci.13947. Epub 2023 Jan 3. Eur J Clin Invest. 2023. PMID: 36576362 Free PMC article. Review.
BACKGROUND: Myocarditis is a rare but significant adverse event associated with COVID-19 vaccination, especially for men under 40. If the risk of myocarditis is not stratified by pertinent risk factors, it may be diluted for high-risk and inflated for low-risk group …
BACKGROUND: Myocarditis is a rare but significant adverse event associated with COVID-19 vaccination, especially for men under …
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.
Wack S, Patton T, Ferris LK. Wack S, et al. J Am Acad Dermatol. 2021 Nov;85(5):1274-1284. doi: 10.1016/j.jaad.2021.07.054. Epub 2021 Aug 4. J Am Acad Dermatol. 2021. PMID: 34363909 Free PMC article. Review.
In this review, we present the current evidence related to COVID-19 vaccine safety and efficacy in patients with IMID and review existing recommendations for vaccination against SARS-CoV-2. Given the current evidence, there is minimal concern that these patie …
In this review, we present the current evidence related to COVID-19 vaccine safety and efficacy in patients with IMID a …
Post COVID-19 vaccine small fiber neuropathy.
Waheed W, Carey ME, Tandan SR, Tandan R. Waheed W, et al. Muscle Nerve. 2021 Jul;64(1):E1-E2. doi: 10.1002/mus.27251. Epub 2021 Apr 28. Muscle Nerve. 2021. PMID: 33851437 Free PMC article. No abstract available.
Should children be vaccinated against COVID-19?
Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Zimmermann P, et al. Arch Dis Child. 2022 Mar;107(3):e1. doi: 10.1136/archdischild-2021-323040. Epub 2021 Nov 3. Arch Dis Child. 2022. PMID: 34732388 Review.
Whether all children under 12 years of age should be vaccinated against COVID-19 remains an ongoing debate. The relatively low risk posed by acute COVID-19 in children, and uncertainty about the relative harms from vaccination and disease mean that the …
Whether all children under 12 years of age should be vaccinated against COVID-19 remains an ongoing debate. The relatively low …
48,355 results
You have reached the last available page of results. Please see the User Guide for more information.